{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and they provided some context. Let me look at the context first. The titles all start with \"Estimating the number of infections and the impact of non-\" and then the passage is \"Lockdown\" repeated a few times. There's also a line that says \"banned Implemented with lockdown.57 24/3/2020\". Hmm, that seems a bit fragmented.\n\nSo, the user probably wants a definition of a lockdown based on the context given. The context mentions lockdown in the context of estimating infections and the impact of non-lockdown measures. The line \"banned Implemented with lockdown.57 24/3/2020\" might be a typo or part of a larger dataset. Maybe the study is about how lockdowns affect infection rates compared to when they're not implemented.\n\nSince the context is limited, I need to define a lockdown in general terms but also relate it to the context provided. A lockdown typically refers to strict restrictions on movement and activities to control the spread of a disease, like during a pandemic. The context suggests that the study is looking at the number of infections and how non-lockdown (or the absence of lockdown) impacts that. The mention of \"banned Implemented with lockdown\" might indicate that in some cases, lockdowns were enforced, and in others, they weren't, leading to different outcomes.\n\nI should explain that a lockdown is a public health measure involving strict limitations on movement and gatherings to reduce disease transmission. The context implies that the study compares scenarios with and without lockdowns to assess their effectiveness in controlling infections. The date 24/3/2020 could be when the lockdown was implemented in a specific region, perhaps during the early stages of the COVID-19 pandemic.\n\nI need to make sure the answer is concise, uses the context provided, and defines lockdown accurately. Since the user might not have access to the full study, I should avoid assuming too much beyond what's given. The key points are the definition of a lockdown and its role in estimating infection numbers and impact as per the context.\n</think>\n\nA **lockdown** is a public health measure that involves strict restrictions on movement, gatherings, and non-essential activities to limit the spread of infectious diseases, such as during a pandemic. Based on the provided context, which references studies on estimating infections and the impact of \"non",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. I need to look through the provided context to find all the mentioned complications.\n\nFirst, looking at the first passage, it lists several complications from most common to least. The main ones are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. That's a good list to start with.\n\nThen, in the third passage about the La Reunion Island outbreak, there's mention of neonates getting CHIKV through perinatal transmission. The complications here include mengoencephalitis (probably a typo for meningoencephalitis) and fetal deaths. Also, the study by Gerardin et al. mentions neonatal infections leading to encephalitis due to vertical transmission from mothers. So encephalitis is a key complication here, especially in newborns.\n\nI should make sure to include both the general complications in adults and the specific ones in neonates. The answer should list all the complications mentioned across the passages. Let me check again to ensure I didn't miss any. The first passage lists respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS issues, and kidney failure. The neonatal cases add encephalitis and fetal deaths. Also, the initial context mentions that severe CHIKF (Chikungunya fever) can lead to these complications, especially in those with underlying conditions.\n\nSo compiling all these, the answer should list all the complications from the passages, noting both the general and neonatal-specific ones. I need to present them clearly, perhaps grouping the most common to least common as mentioned, and then the neonatal complications separately.\n</think>\n\nThe complications associated with Chikungunya virus (CHIKV) include:  \n1. **Respiratory failure**  \n2. **Cardiovascular decompensation**  \n3. **Meningoencephalitis** (inflammation of the brain and meninges)  \n4. **Severe acute hepatitis**  \n5. **Severe cutaneous effects** (skin-related complications)  \n6. **Other central nervous system (CNS) problems**  \n7. **Kidney failure**  \n\nAdditionally, **",
      "retrieved_chunks": [
        "Title: Chikungunya: A Potentially Emerging Epidemic?\nPassage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: and complications.\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis. Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al. theorized that motherto-child transmission most likely happens transplacentally shortly before delivery .\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: A similar study by Gerardin et al. reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 0.2777777777777778,
      "computed_utilization": 0.2777777777777778,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what Clade A contains based on the provided context. First, I need to look through the passages given.\n\nLooking at the first passage, it talks about the 1A swine lineage, which has 1,889 viruses from 34 countries collected from 2010 to the present. It mentions that the 1A lineage is divided into three second-order divisions. However, the question is about Clade A, but the passage refers to 1A, 1A.1, etc. There's no mention of Clade A specifically here. \n\nThe second passage discusses the 1C lineage with 315 viruses from China and South Korea. It mentions \"Other-Avian\" clades but again, no Clade A. \n\nThe third passage is about the 1B human seasonal lineage. It mentions exceptions in 1B.1 and 1B.2 but not Clade A. \n\nThe fourth passage mentions seven clades but refers to the 2009 H1N1 pandemic and surveillance in different regions. Still, no Clade A is mentioned. \n\nWait, the user might be confusing \"Clade A\" with the first-order clades like 1A, 1B, 1C. The question says \"Clade A,\" but in the context, the clades are labeled with numbers and letters like 1A.1, 1C.2, etc. However, none of the passages explicitly mention a \"Clade A\" by that exact name. The first passage refers to the 1A lineage, which is a first-order clade. Maybe the user is referring to the 1A lineage as Clade A? But the answer options need to be based strictly on the provided text. \n\nSince none of the passages mention \"Clade A\" directly, perhaps the answer is that there's no information provided about Clade A in the given context. Alternatively, maybe there's a misinterpretation here. The user might have thought that \"Clade A\" is equivalent to one of the mentioned lineages, but according to the provided texts, the lineages are 1A, 1B, 1C, etc. So unless there's a specific mention of Clade A, the answer would be that the context doesn't contain information about Clade A. \n\nTherefore,",
      "retrieved_chunks": [
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 . Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade. The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 . For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations . Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents."
      ],
      "computed_relevance": 0.1875,
      "computed_utilization": 0.5625,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of the 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. I need to look through the provided context to find relevant information.\n\nFirst, I remember that the S1 subunit is part of the spike glycoprotein, which is divided into S1 and S2. The S1 has a receptor-binding domain (RBD). The context mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the bat SARS-like CoVs and human SARS-CoV. That's a key point. \n\nThen, there's something about the core domain of the RBD being highly conserved. But the amino acid differences are in the external subdomain, which interacts directly with the host receptor. This suggests that while the core is similar, the part that binds to the host might be different. \n\nAlso, the context notes that unlike 2019-nCoV and human SARS-CoV, some bat SARS-related CoVs have deletions in the RBD. However, 2019-nCoV doesn't have those deletions. Additionally, the external subdomain of the RBD in 2019-nCoV has only 40% identity with other SARS-related coronaviruses, indicating significant differences in that region.\n\nPutting this together, the S1 subunit of 2019-nCoV is about 70% identical to SARS-like CoVs and human SARS-CoV. The core RBD is conserved, but the external part, which is crucial for receptor interaction, has more variations. This might explain differences in host receptor usage and transmission. The answer should highlight the 70% identity, the conserved core, and the variable external subdomain.\n</think>\n\nThe S1 subunit of the 2019-nCoV (SARS-CoV-2) shares **approximately 70% amino acid identity** with the S1 subunits of bat SARS-like coronaviruses (SARSr-CoVs) and human SARS-CoV. While the **core domain of the receptor-binding domain (RBD)** in the S1 subunit is highly conserved across these viruses, most amino acid differences are localized to the",
      "retrieved_chunks": [
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits. The S1 subunit contains a signal peptide, followed by an N-terminal domain and receptor-binding domain , while the S2 subunit contains conserved fusion peptide , heptad repeat 1 and 2, transmembrane domain , and cytoplasmic domain . We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV . Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ). Most of the amino acid differences of RBD are located in the external subdomain, which is responsible for the direct interaction with the host receptor. Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV. But some\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: bat, civet and human SARS coronaviruses. However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8. The SL3 contains trans-cis motif . The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b. The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.15789473684210525,
      "computed_utilization": 0.15789473684210525,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" I need to base my answer on the provided context.\n\nFirst, I'll go through each of the passages to gather relevant information. \n\nIn the first passage, it mentions that B. subtilis is a probiotic used to treat intestinal diseases like colitis. It helps restore gut microflora by increasing beneficial bacteria and decreasing harmful ones. It also maintains gut barrier integrity and reduces inflammation. The study cited is Bene et al., 2017.\n\nThe second passage talks about Bacillus and Lactobacillus species in fermented foods and probiotics. Specific products like Biosubtyl and Biosporin are listed as containing Bacillus. This shows that B. subtilis is used commercially as a probiotic.\n\nThe third passage discusses how Bacillus species, including B. subtilis, were once thought to be transient in the gut but are now known to colonize it. They're adapted to the gastrointestinal tract and present in higher amounts than just from food intake. This indicates that B. subtilis is a part of the normal gut microbiome, not just a passing microbe.\n\nThe fourth passage details the substances produced by B. subtilis: surfactins, fengycins, and iturins. Surfactins have antimicrobial and antiviral properties, protect against antibiotics from other species, and modulate inflammation by affecting cytokines. This shows the biochemical roles B. subtilis plays in the gut.\n\nPutting this together, Bacillus subtilis is a probiotic bacterium that's part of the gut microbiome. It's used in various probiotic products, helps maintain gut health by balancing microflora, supports gut barrier function, and produces compounds that have antimicrobial and anti-inflammatory effects. It's also found in fermented foods and is effective against intestinal diseases like colitis.\n\nI need to make sure the answer covers its role as a probiotic, its presence in the gut, the specific benefits it provides (like restoring microflora balance, reducing inflammation), and the bioactive compounds it produces. Also mention its use in commercial products and traditional foods.\n</think>\n\nBacillus subtilis is a probiotic bacterium belonging to the Bacillus genus, recognized for its beneficial roles in maintaining intestinal health. It is part of the gut microbiome and has been shown to restore balance in",
      "retrieved_chunks": [
        "Title: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: The efficacy of Lactobacillus and Bacillus in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer was demonstrated . In particular, treatment of colorectal colitis in mice with probiotic B. subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased . B. subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B. subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp. as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only. Bacillus spp. have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B. subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 . The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action . They protect bacilli against extracellular antibiotic-containing vesicles of other species and inhibit phospholipase A2 resulting in subsequent downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines ."
      ],
      "computed_relevance": 0.35,
      "computed_utilization": 0.35,
      "computed_completeness": 0.8571428571428571,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, this seems to discuss multi-wave pandemics rather than single-wave. But maybe the mention of the 1889 pandemic's three waves could be part of the answer if considering how past pandemics were studied, even if they weren't single-wave.\n\nNext, the second context about the 2009 pandemic in Hong Kong talks about convalescent plasma treatment and research on the origins of the 2009 strain. It mentions studies on epidemiology and control but doesn't directly address single-wave pandemics. However, the 2009 pandemic itself might have had multiple waves, so this might not be relevant.\n\nThe third context is about economic analysis of mitigation strategies for different pandemic severities. It references studies using simulation models and data from the 2009 pandemic. The 2009 pandemic (pH1N1) is known to have had multiple waves, so again, not a single-wave example. But the economic models might have considered scenarios with varying wave structures, though the context doesn't specify single-wave analysis.\n\nThe fourth context from Taiwan discusses the 2009 pH1N1 pandemic and uses a Richards model variation to analyze multi-wave epidemics. It distinguishes between turning points in multi-wave scenarios. This is about multi-wave, not single-wave, but the methodology might be relevant if past research on single-wave pandemics used similar models. However, the context doesn't mention single-wave pandemics directly.\n\nPutting this together, the contexts provided don't explicitly mention research on severe, single-wave pandemics. They focus on multi-wave pandemics like 1889, 1918, and 2009. The user's question is about past research on single-wave, but the available contexts don't provide examples of such research. However, the first context does mention the",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies. 56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al. . The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic. Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking \"How many reported viral pneumonia?\" based on the provided context. I need to look through each of the given passages to find any numbers related to viral pneumonia cases.\n\nFirst, looking at the first context about the 2019-nCoV. It mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection as of January 26, 2020. That's a specific number related to viral pneumonia caused by that virus.\n\nNext, the second context is about influenza viral pneumonia. It talks about bacterial co-infections in the 2009 H1N1 pandemic, with 29% of 77 fatal cases having bacterial pneumonia. But the question is about viral pneumonia, so maybe the 77 cases here are viral? Wait, the 77 cases are of H1N1v 2009 infection, which is viral. But the 29% is about bacterial co-infection, not the total viral cases. The passage doesn't give a total number of viral pneumonia cases here, just the co-infection rate.\n\nThird context also discusses influenza attack rates. It mentions 29% in adults over 15 and 61% in children under 15 during the 2009 pandemic in La Gloria. But again, these are attack rates, not the total number of cases. The user is asking for how many were reported, so unless there's a specific number given, this might not help.\n\nFourth context is about pneumonia in adults with seasonal influenza in the US from 2005-2008. It states that patients with pneumonia were more likely to receive antiviral therapy. However, there's no specific number given for the total cases of viral pneumonia here either.\n\nSo the only concrete number comes from the first context: 2744 confirmed cases of 2019-nCoV infected pneumonia. The other contexts discuss influenza but don't provide specific numbers of reported cases, just percentages or attack rates. Therefore, the answer should be 2744.\n</think>\n\nThe context provided for the 2019 novel coronavirus (2019-nCoV) reports **2,744 confirmed cases of pneumonia** with 2019-nCoV infection as of 24:00 on",
      "retrieved_chunks": [
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths. A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation. A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients . The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days .\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age . However, these rates may be different in geographic areas of low population density.\n\nTitle: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01]."
      ],
      "computed_relevance": 0.09090909090909091,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage under the title \"MERS coronavirus: diagnostics, epidemiology and transmission,\" the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. \n\nI should check the other passages to make sure there's no conflicting information. The other sections talk about genetic variations, recombination, and the importance of sequencing, but they don't mention different methods being used more frequently. The first passage clearly states that high throughput or deep sequencing is the primary method. \n\nSo the answer should be that high throughput or deep sequencing methods were used for complete genome deduction. I need to present this in a clear, concise way without adding extra details from other parts unless necessary. The key point is the method mentioned in the first passage.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach enabled comprehensive genomic analysis and was widely applied to study the emerging MERS-CoV outbreak.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic . Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur . Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC"
      ],
      "computed_relevance": 0.07142857142857142,
      "computed_utilization": 0.07142857142857142,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the relevant information.\n\nFirst, looking at the first context: They mention using split-GFP-tagged viral proteins and monitoring GFP expression during passaging with immunofluorescence microscopy. But the question is about tracking the spread, so maybe this isn't the main one.\n\nSecond context: They used an inverted fluorescence microscope to monitor plates after applying an overlay. They imaged a square subset of each well periodically using a CellInsight CX5 platform with a 4X objective. The settings were standardized, including exposure time. This seems like in vitro tracking within cell cultures.\n\nThird context: Talks about in vivo imaging using multi-photon intravital microscopy. They mention using reporter genes like EGFP and mCherry in mouse lines, allowing long-term tracking without bleaching. Also, visualization of small structures. This is about in vivo tracking in live animals.\n\nFourth context: They used IVIS for whole-organ imaging of lungs ex vivo and flow cytometry to analyze infection progression in antigen-presenting cells. They observed GFP in lungs and tracked infection spread from airways to deeper areas. This is also in vivo but uses different methods.\n\nSo the answer should combine the methods from different contexts. The spread was tracked using fluorescence microscopy (inverted and multi-photon), high-content screening platforms, IVIS for whole-organ imaging, and flow cytometry. Each context contributes a different method depending on the study's setup (in vitro vs. in vivo). Need to mention all relevant techniques mentioned across the contexts.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using multiple imaging techniques across different studies. In vitro, researchers used **inverted fluorescence microscopy** to monitor GFP expression in cell cultures, with periodic imaging via a **CellInsight CX5 High Content Screening Platform** (fixed exposure settings and 4X objective). For in vivo studies, **multi-photon intravital microscopy** enabled long-term tracking of fluorescent proteins (e.g., EGFP) in live animals, while **IVIS** (In Vivo Imaging System) allowed whole-organ imaging of GFP expression in lungs ex vivo. Additionally, **flow cytometry** was employed to analyze GFP+ immune cells (e.g., dendritic cells, macrophages) during infection progression. These",
      "retrieved_chunks": [
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator . For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective . Microscope settings were held standard across all trials, with exposure time fixed at 0.0006 s for each image. One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .\n\nTitle: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter . Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry . Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible. Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs . The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection ."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to look through the given context. The first passage mentions \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination.\" The second one is \"Fever-CT disinfection procedures after examination.\" The third is similar but mentions \"fever-CTs) after these sterilization procedures.\" The fourth passage says \"equipment and prepares to disinfect the imaging equipment immediately after the examination.\"\n\nPutting this together, the key points are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The procedures are referred to as \"noncontaminated\" and \"sterilization procedures.\" The fourth passage emphasizes doing this immediately after the examination. \n\nThe answer should mention that the CT scanner should be disinfected immediately after the examination using specific sterilization procedures. The terms \"noncontaminated\" and \"sterilization\" are used in the context, so those should be included. Also, the mention of \"fever-CTs\" might be a typo or specific term, but since it's repeated, maybe it's part of the protocol. However, the main point is the immediate disinfection after the exam using the specified procedures. \n\nI need to make sure the answer is concise and directly addresses the steps mentioned. The user probably wants a clear, step-by-step answer based on the context provided. Since the context doesn't go into detailed steps beyond the immediate action, the answer should focus on that. So the answer would be that the recommended procedure is to disinfect the CT scanner immediately after the examination using noncontaminated sterilization procedures.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment** following the examination using **noncontaminated sterilization procedures**. This ensures the equipment is properly sanitized to prevent cross-contamination after suspected or confirmed COVID-19 cases.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures.\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}